| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/26/2003 | CN1399680A 上皮细胞生长抑制剂 Epithelial cell growth inhibitor |
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399675A Method of proliferating natural killer cells |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/26/2003 | CN1399556A APRIL receptor (BCMA) and uses thereof |
| 02/26/2003 | CN1399553A Composition containing muscle-derived active agents |
| 02/26/2003 | CN1399545A Treatment of certain cancers associated with weight gain |
| 02/26/2003 | CN1399539A Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 02/26/2003 | CN1398898A Extraction and separation process of ash tree flower sporophore polyglycopeptide |
| 02/26/2003 | CN1398897A Serial synthetic antibacterial peptide |
| 02/26/2003 | CN1398896A Hybrid peptide with vascularization inhibiting activity |
| 02/26/2003 | CN1398863A Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them |
| 02/26/2003 | CN1398637A Thymosin alpha-1 microball prepn and its prepn process |
| 02/26/2003 | CN1398627A Chinese herbal medicine tumor-eliminating drop and its recipe |
| 02/26/2003 | CN1398593A Tumor cell growth inhibitor and its prepn process |
| 02/26/2003 | CN1398592A Medicine composition for treating tumor and cardiac and cerebral vascular diseases |
| 02/26/2003 | CN1398591A Anticancer cantharidoid-glycosamine coupler and its prepn and application |
| 02/26/2003 | CN1102066C Medicine for treating AIDS and tumor and its preparing process |
| 02/26/2003 | CN1102048C Anticancer detoxicating pill and its preparing process |
| 02/26/2003 | CN1102047C Reversing agent for multi-medicine resistance of tumor cells |
| 02/26/2003 | CA2454667A1 Remedies for mammary cancer |
| 02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | CA2419744A1 A novel crystal of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-¬n-(4-phenoxyphenylcarbonyl)amino|pentanamide and a method for the preparation thereof and a pharmaceutical agent comprising the same as active ingredient |
| 02/25/2003 | US6525196 5HT1 antagonists for antidepressant therapy |
| 02/25/2003 | US6525102 Increasing storage stability of interleukin-2 by incorporating free base form arginine and succinic acid |
| 02/25/2003 | US6525089 Pharmaceutical composition containing decursin |
| 02/25/2003 | US6525083 Antidiabetic agents, antilipemic agents, anticholesterol agents |
| 02/25/2003 | US6525077 Cyanoguanidine prodrugs |
| 02/25/2003 | US6525074 Peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525063 3,7-dimethyl-1,5-diazaanthraquinone for example |
| 02/25/2003 | US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma |
| 02/25/2003 | US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine; |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525019 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 02/25/2003 | US6524855 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 02/25/2003 | US6524823 Vasopermeability-enhancing conjugates |
| 02/25/2003 | US6524815 A promoter which is active in the vascular endothelium and to its use for expressing genes of interest in this tissue |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524625 Physiologically active extract obtained from indigo plant polygonum tinctorium |
| 02/25/2003 | US6524587 Inoculation of a Dengue fever virus with nil mortality and subsequent injection of irradiated tumor cells derived from the patient. This therapy will safely reduce the tumor burden by 90-99.9% |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
| 02/25/2003 | US6524576 Probiotic composition; veterinary feed additive; food additive; microorganisms dispenser; eliminating an oil pollution; restoring organic fumes degrading microorganism population in a biofilter |
| 02/25/2003 | US6524575 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/25/2003 | US6524554 Radiopharmaceuticals comprised of one to three pentapeptides attached to metal chelator or bonding moiety, to which is attached radioisotope, optionally further comprising linking group between peptides and chelator; bind to tuftsin receptors |
| 02/25/2003 | US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/25/2003 | CA2238331C Cancerous metastasis inhibitors containing uracil derivatives |
| 02/22/2003 | CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | WO2002016323A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |
| 02/21/2003 | CA2420205A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | CA2399325A1 Carbohydrate-based whole cell cancer vaccines |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014702A2 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | WO2003014335A1 Process for the maturation of dentritic cells and a vaccine |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | WO2003014316A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 02/20/2003 | WO2003014301A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | WO2003014300A2 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014299A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014163A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | WO2003014159A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | WO2003014157A2 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 02/20/2003 | WO2003014144A2 Molecule |
| 02/20/2003 | WO2003014141A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 02/20/2003 | WO2003014137A1 Adenosine a3 receptor agonists |
| 02/20/2003 | WO2003014128A2 Tumour inhibiting cerium compounds |
| 02/20/2003 | WO2003014127A1 Antitumoral analogs |
| 02/20/2003 | WO2003014121A1 Compounds, derivatives, compositions, preparation and uses |
| 02/20/2003 | WO2003014117A1 3-substituted pyrrolo[2.1-a]isoquinoline derivatives |
| 02/20/2003 | WO2003014116A1 Pyrrolo[2.1-a]isoquinoline derivatives |
| 02/20/2003 | WO2003014115A1 3-substituted pyrrolo (2.1-a) isoquinoline derivatives |
| 02/20/2003 | WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014102A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 02/20/2003 | WO2003014101A1 Hydroxamic acid derivatives |
| 02/20/2003 | WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014073A1 Fatty acid compounds, preparation and uses thereof |
| 02/20/2003 | WO2003014069A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/20/2003 | WO2003014063A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof |
| 02/20/2003 | WO2003013655A2 Carbonic anhydrase inhibitors |